We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

1347. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 1002 of 5 November 2024, given that Melatonin has not been reviewed since 2008, if he will instruct the NCPE to review and include this product for reimbursement under the Community Drugs Schemes; and if he will make a statement on the matter. [46423/24]

Comment on this
Stephen Donnelly Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this